Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 16Stomach Neoplasms 8Rectal Neoplasms 8Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasm Metastasis 6Adenocarcinoma Of Esophagus 6Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Neoplasms 4Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Anus Neoplasms 2Advanced Solid Tumour 2Solid Tumors 1Peritoneal Neoplasms 1Neoplasms 1HIV Infections 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anal Canal Carcinoma 1

Interventions

Gemcitabine 6durvalumab 5Cisplatin 5Oxaliplatin 3Irinotecan 3Folfox protocol 3zanidatamab 2tremelimumab 2pembrolizumab 2Fluorouracil 2Capecitabine 2trastuzumab deruxtecan 1poly ICLC 1niraparib 1neratinib 1lenvatinib 1ivosidenib 1futibatinib 1envafolimab 1encorafenib 1brigimadlin 1binimetinib 1apatinib 1Trastuzumab 1Self Expandable Metallic Stents 1Radiation 1Psilocybin 1Peptides 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Capecitabine × 30 days × Clear all
NCT07606599 2026-05-26

A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
398 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07582315 2026-05-22

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
538 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡